Infectious Disease

The team will develop a rigorous outbreak surveillance and detection system that could help public health officials contain outbreaks at their source.

An interdisciplinary team has developed a game-changing diagnostic test for SARS-CoV-2 that is fast, reliable, low-cost and capable of differentiating between COVID-19 and influenza.

Reconstructing the early unnoticed spread of COVID-19 offers important insights to help countries prepare for future outbreaks.

UF researchers identify first known instances of two different types of viruses in Haitian children.

Dr. Ira Longini and other WHO researchers offer guidance on approaches to track, understand and mitigate COVID-19 virus variants.

Unless MRSA carriers develop an infection or are tested for the bacteria, they may not even know they carry it, yet they are at significant risk for premature death.

Infectious disease modeler and biostatistician Ira Longini is applying decades of experience to help design and analyze clinical trials to identify a safe and effective COVID-19 vaccine.

Which global distribution strategy for a hypothetical COVID-19 vaccine will save the most lives?

The WHO Solidarity Trial will test multiple vaccines at possibly hundreds of sites in tens of thousands of participants to find vaccines with at least 50% efficacy.